Companies / SOM Biotech
SOM Biotech
Barcelona, Spain
The company is a late-stage clinical development company pioneering an Artificial Intelligence platform for drug discovery dedicated to rare CNS disorders.
SOM Biotech, based in Barcelona, Spain, has 2 investors on file, among them Convergence Partners and Monte Carlo Capital. Its site was last checked 10 Nov 2026: site answers.
Investors
2 investors on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital |
More from Convergence Partners
32 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (69%), Gaming (5%), Consumer (5%).
See Convergence Partners' full profile · Who invests alongside it
More from Monte Carlo Capital
41 companies on its checked portfolioIts portfolio leans to AI & Machine Learning (25%), Fintech (14%), Industrial & Manufacturing (12%).
See Monte Carlo Capital's full profile · Who invests alongside it
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get SOM Biotech and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Convergence Partners adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/sombiotech.com/investors
# also
GET /v1/companies/sombiotech.com
GET /v1/companies/sombiotech.com/news